| 1. |
Wang Z, Wang X, Hao G, et al. A national study of the prevalence and risk factors associated with peripheral arterial disease from China: the China hypertension survey, 2012–2015. Int J Cardiol, 2019, 275: 165-170.
|
| 2. |
Roumeliotis S, Roumeliotis A, Dounousi E, et al. Biomarkers of vascular calcification in serum. Adv Clin Chem, 2020, 98: 91-147.
|
| 3. |
Lanzer P, Hannan FM, Lanzer JD, et al. Medial arterial calcification: JACC state-of-the-art review. J Am Coll Cardiol, 2021, 78(11): 1145-1165.
|
| 4. |
中華醫學會外科學分會血管外科學組. 下肢動脈硬化閉塞癥診治指南. 中華普通外科學文獻(電子版), 2016, 10(1): 1-18.
|
| 5. |
Golledge J. Update on the pathophysiology and medical treatment of peripheral artery disease. Nat Rev Cardiol, 2022, 19(7): 456-474.
|
| 6. |
Abela GS. Historical background, development, and future trends of lasers in cardiovascular disease // Abela GS. Lasers in cardiovascular medicine and surgery: fundamentals and techniques. Boston, MA: Springer US, 1990, 9-17.
|
| 7. |
Rocha-Singh KJ, Zeller T, Jaff MR. Peripheral arterial calcification: prevalence, mechanism, detection, and clinical implications. Catheter Cardiovasc Interv, 2014, 83(6): E212-E220. doi: 10.1002/ccd.25387.
|
| 8. |
Kang IS, Lee W, Choi BW, et al. Semiquantitative assessment of tibial artery calcification by computed tomography angiography and its ability to predict infrapopliteal angioplasty outcomes. J Vasc Surg, 2016, 64(5): 1335-1343.
|
| 9. |
Patel MR, Conte MS, Cutlip DE, et al. Evaluation and treatment of patients with lower extremity peripheral artery disease: consensus definitions from Peripheral Academic Research Consortium (PARC). J Am Coll Cardiol, 2015, 65(9): 931-941.
|
| 10. |
王盛, 史振宇, 馮海. 下肢動脈疾病腔內減容規范化應用中國專家共識(2024版). 中國實用外科雜志, 2024, 44(12): 1328-1338.
|
| 11. |
Bürckenmeyer F, Aschenbach R, Diamantis I, et al. Excimer laser atherectomy in complex peripheral artery disease: a prospective European registry. J Cardiovasc Surg (Torino), 2021, 62(2): 153-161.
|
| 12. |
Shammas NW, Coiner D, Shammas GA, et al. Distal embolic event protection using excimer laser ablation in peripheral vascular interventions: results of the DEEP EMBOLI registry. J Endovasc Ther, 2009, 16(2): 197-202.
|
| 13. |
Babaev A, Zavlunova S, Attubato MJ, et al. Orbital atherectomy plaque modification assessment of the femoropopliteal artery via intravascular ultrasound (TRUTH study). Vasc Endovascular Surg, 2015, 49(7): 188-194.
|
| 14. |
Wardle BG, Ambler GK, Radwan RW, et al. Atherectomy for peripheral arterial disease. Cochrane Database Syst Rev, 2020, 9(9): CD006680. doi: 10.1002/14651858.CD006680.pub3.
|
| 15. |
McKinsey JF, Zeller T, Rocha-Singh KJ, et al. Lower extremity revascularization using directional atherectomy: 12-month prospective results of the DEFINITIVE LE study. JACC Cardiovasc Interv, 2014, 7(8): 923-933.
|
| 16. |
Bai H, Fereydooni A, Zhang Y, et al. Trends in utilization and outcomes of orbital, laser, and excisional atherectomy for lower extremity revascularization. J Endovasc Ther, 2022, 29(3): 389-401.
|
| 17. |
Rocha-Singh KJ, Sachar R, DeRubertis BG, et al. Directional atherectomy before paclitaxel coated balloon angioplasty in complex femoropopliteal disease: The VIVA REALITY study. Catheter Cardiovasc Interv, 2021, 98(3): 549-558.
|
| 18. |
Roberts D, Niazi K, Miller W, et al. Effective endovascular treatment of calcified femoropopliteal disease with directional atherectomy and distal embolic protection: final results of the DEFINITIVE Ca++ trial. Catheter Cardiovasc Interv, 2014, 84(2): 236-244.
|
| 19. |
Zeller T, Rastan A, Schwarzw?lder U, et al. Percutaneous peripheral atherectomy of femoropopliteal stenoses using a new-generation device: six-month results from a single-center experience. J Endovasc Ther, 2004, 11(6): 676-685.
|
| 20. |
Hansen DD, Auth DC, Vracko R, et al. Rotational atherectomy in atherosclerotic rabbit iliac arteries. Am Heart J, 1988, 115(1 Pt 1): 160-165.
|
| 21. |
Gandini R, Pratesi G, Merolla S, et al. A single-center experience with phoenix atherectomy system in patients with moderate to heavily calcified femoropopliteal lesions. Cardiovasc Revasc Med, 2020, 21(5): 676-681.
|
| 22. |
Dukic D, Martin K, Lichtenberg M, et al. Novel therapeutic concepts for complex femoropopliteal lesions using the jetstream atherectomy system. J Endovasc Ther, 2024, 31(6): 1218-1226.
|
| 23. |
Giusca S, Hagstotz S, Lichtenberg M, et al. Phoenix atherectomy for patients with peripheral artery disease. EuroIntervention, 2022, 18(5): e432-e442. doi: 10.4244/EIJ-D-21-01070.
|
| 24. |
Maehara A, Mintz GS, Shimshak TM, et al. Intravascular ultrasound evaluation of JETSTREAM atherectomy removal of superficial calcium in peripheral arteries. EuroIntervention, 2015, 11(1): 96-103.
|
| 25. |
Babaev A, Zavlunova S, Attubato MJ, et al. Orbital atherectomy plaque modification assessment of the femoropopliteal artery via intravascular ultrasound (TRUTH Study). Vasc Endovascular Surg, 2015, 49(7): 188-194.
|
| 26. |
Giannopoulos S, Secemsky EA, Mustapha JA, et al. Three-year outcomes of orbital atherectomy for the endovascular treatment of infrainguinal claudication or chronic limb-threatening ischemia. J Endovasc Ther, 2020, 27(5): 714-725.
|
| 27. |
張瑞星, 張鉦. 準分子激光冠狀動脈斑塊消融術應用. 國際心血管病雜志, 2023, 50(2): 69-73.
|
| 28. |
Tepe G, Brodmann M, Werner M, et al. Intravascular lithotripsy for peripheral artery calcification: 30-day outcomes from the randomized Disrupt PAD Ⅲtrial. JACC Cardiovasc Interv, 2021, 14(12): 1352-1361.
|
| 29. |
Sanders KM, Schneider PA, Conte MS, et al. Endovascular treatment of high-risk peripheral vascular occlusive lesions: a review of current evidence and emerging applications of intravascular lithotripsy, atherectomy, and paclitaxel-coated devices. Semin Vasc Surg, 2021, 34(4): 172-187.
|
| 30. |
Brodmann M, Werner M, Brinton TJ, et al. Safety and performance of lithoplasty for treatment of calcified peripheral artery lesions. J Am Coll Cardiol, 2017, 70(7): 908-910.
|
| 31. |
Brodmann M, Werner M, Holden A, et al. Primary outcomes and mechanism of action of intravascular lithotripsy in calcified, femoropopliteal lesions: results of Disrupt PAD Ⅱ. Catheter Cardiovasc Interv, 2019, 93(2): 335-342.
|
| 32. |
Tepe G, Brodmann M, Bachinsky W, et al. Intravascular lithotripsy for peripheral artery calcification: mid-term outcomes from the randomized Disrupt PAD Ⅲ trial. J Soc Cardiovasc Angiogr Interv, 2022, 1(4): 100341. doi: 10.1016/j.jscai.2022.100341.
|
| 33. |
Corl JD, Clair D, Mwipatayi P, et al. FORWARD PAD IDE/Feasibility studies: primary endpoint analysis of a novel non-balloon-based peripheral IVL catheter. JACC Cardiovasc Interv, 2025, 18(3): 398-399.
|
| 34. |
Dubosq M, Patterson BO, Azzaoui R, et al. Protocol adaptation of optical coherence tomography in lower limb arteries revascularization. Ann Vasc Surg, 2019, 57: 257-260.
|
| 35. |
Divakaran S, Parikh SA, Hawkins BM, et al. Temporal trends, practice variation, and associated outcomes with ivus use during peripheral arterial intervention. JACC Cardiovasc Interv, 2022, 15(20): 2080-2090.
|
| 36. |
Lee JT, Fang TD, White RA. Applications of intravascular ultrasound in the treatment of peripheral occlusive disease. Semin Vasc Surg, 2006, 19(3): 139-144.
|
| 37. |
Schwindt AG, Bennett JG, Crowder WH, et al. Lower extremity revascularization using optical coherence tomography-guided directional atherectomy: final results of the evaluation of the pantheris optical coherence tomography imaging atherectomy system for use in the peripheral vasculature (VISION) study. J Endovasc Ther, 2017, 24(3): 355-366.
|
| 38. |
Yazu Y, Fujihara M, Takahara M, et al. Intravascular ultrasound-based decision tree model for the optimal endovascular treatment strategy selection of femoropopliteal artery disease-results from the ONION Study. CVIR Endovasc, 2022, 5(1): 52. doi: 10.1186/s42155-022-00328-9.
|
| 39. |
Allan RB, Puckridge PJ, Spark JI, et al. The impact of intravascular ultrasound on femoropopliteal artery endovascular interventions: a randomized controlled trial. JACC Cardiovasc Interv, 2022, 15(5): 536-546.
|
| 40. |
Krishnan P, Sharma R, Avadhani S, et al. IVUS improves outcomes with SUPERA stents for the treatment of superficial femoral-popliteal artery disease. J Endovasc Ther, 2025, 32(2): 475-480.
|
| 41. |
Kurata N, Iida O, Takahara M, et al. Clinical impact of the size of drug-coated balloon therapy on restenosis rate in femoropopliteal lesions. J Endovasc Ther, 2023, 30(2): 269-280.
|